In state settlement, Teva agrees to stop marketing opioids in Oklahoma

Generic drug manufacturer Teva Pharmaceuticals USA has agreed not to promote opioids in any way in Oklahoma for more than 27 years as part of a settlement of the state’s lawsuit over the deadly opioid crisis.

The promotion ban was one of the key new details to emerge Monday when the settlement became public. The three-point ban will be in effect until Dec. 31, 2026.

As previously announced, Teva Pharmaceuticals USA and affiliated companies agreed in May to pay $85 million to be dropped from the lawsuit. The settlement was filed Monday after Cleveland County District Judge Thad Balkman signed off on it.

https://www.marketscreener.com/TEVA-PHARMACEUTICAL-INDUS-56537293/news/Teva-Pharmaceutical-Industries-As-part-of-settlement-with-state-Teva-Pharmaceuticals-agrees-to-st-28810624/